We are live on ! Find out more
TECH icon

Bio-Techne

243 hedge funds and large institutions have $3.64B invested in Bio-Techne in 2015 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 88 increasing their positions, 96 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less capital invested

Capital invested by funds: $3.69B → $3.64B (-$54.3M)

8% less repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 96

4% less funds holding

Funds holding: 252243 (-9)

33% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 21

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

67% less call options, than puts

Call options by funds: $217K | Put options by funds: $660K

Holders
243
Holders Change
-9
Holders Change %
-3.57%
% of All Funds
6.51%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
14
Increased
88
Reduced
96
Closed
21
Calls
$217K
Puts
$660K
Net Calls
-$443K
Net Calls Change
-$192K

TECH Hedge Fund Activity: Q2 2015 in Review

243 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2015, worth a combined $3.64B — down 1.5% from $3.69B a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of TECH and 14 opened new positions — a net loss of 7 holders — while 96 trimmed existing stakes and 88 added.

The largest buyer was First Trust Advisors, adding an estimated $49.6M. The largest seller was Kornitzer Capital Management, cutting an estimated $22.9M.

  • 243 institutional investors held Bio-Techne (TECH) as of Q2 2015, down from 252 in Q1 2015.
  • Funds reported $3.64B of Bio-Techne stock for Q2 2015, down 1.5% quarter-over-quarter.
  • 14 funds opened new Bio-Techne positions in Q2 2015 and 21 closed out, a net change of -7 holders.
  • The largest Bio-Techne buyer in Q2 2015 was First Trust Advisors, an estimated $49.6M added.
  • The largest Bio-Techne seller in Q2 2015 was Kornitzer Capital Management, an estimated $22.9M sold.

Based on aggregated 13F filings for Q2 2015.